Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy

被引:53
作者
Kron, T
Grigorov, G
Yu, E
Yartsev, S
Chen, JZ
Wong, EG
Rodrigues, G
Trenka, K
Coad, T
Bauman, G
Van Dyk, J
机构
[1] London Reg Canc Ctr, Dept Radiat Oncol, London, ON N6A 4L6, Canada
[2] London Reg Canc Ctr, Dept Phys, London, ON N6A 4L6, Canada
[3] London Reg Canc Ctr, Dept Engn, London, ON N6A 4L6, Canada
关键词
D O I
10.1088/0031-9155/49/16/014
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Lung cancer treatment is one of the most challenging fields in radiotherapy. The aim of the present study was to investigate what role helical tomotherapy (HT), a novel approach to the delivery of highly conformal dose distributions using intensity-modulated radiation fan beams, can play in difficult cases with large target volumes typical for many of these patients. Tomotherapy plans were developed for 15 patients with stage III inoperable non-small-cell lung cancer. While not necessarily clinically indicated, elective nodal irradiation was included for all cases to create the most challenging scenarios with large target volumes. A 2 cm margin was used around the gross tumour volume (GTV) to generate primary planning target volume (PTV2) and 1 cm margin around elective nodes for secondary planning target volume (PTV1) resulting in PTV1 volumes larger than 1000 cm(3) in 13 of the 15 patients. Tomotherapy plans were created using an inverse treatment planning system (TomoTherapy Inc.) based on superposition/convolution dose calculation for a fan beam thickness of 25 mm and a pitch factor between 0.3 and 0.8. For comparison, plans were created using an intensity-modulated radiation therapy (IMRT) approach planned on a commercial treatment planning system (TheraplanPlus, Nucletron). Tomotherapy delivery times for the large target volumes were estimated to be between 4 and 19 min. Using a prescribed dose of 60 Gy to PTV2 and 46 Gy to PTV1, the mean lung dose was 23.8 +/- 4.6 Gy. A 'dose quality factor' was introduced to correlate the plan outcome with patient specific parameters. A good correlation was found between the quality of the HT plans and the IMRT plans with HT being slightly better in most cases. The overlap between lung and PTV was found to be a good indicator of plan quality for HT. The mean lung dose was found to increase by approximately 0.9 Gy per percent overlap volume. Helical tomotherapy planning resulted in highly conformal dose distributions. It allowed easy achievement of two different dose levels in the target simultaneously. As the overlap between PTV and lung volume is a major predictor of mean lung dose, future work will be directed to control of margins. Work is underway to investigate the possibility of breath-hold techniques for tomotherapy delivery to facilitate this aim.
引用
收藏
页码:3675 / 3690
页数:16
相关论文
共 42 条
[1]  
Curran WJ, 2000, P AN M AM SOC CLIN, V19, p484a
[2]  
DeVita VT., 2001, CANC PRINCIPLES PRAC
[3]   Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial [J].
Dillman, RO ;
Herndon, J ;
Seagren, SL ;
Eaton, WL ;
Green, MR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1210-1215
[4]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122
[5]  
Endo Masahiro, 2003, Radiat Med, V21, P17
[6]   Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) [J].
Graham, MV ;
Purdy, JA ;
Emami, B ;
Harms, W ;
Bosch, W ;
Lockett, MA ;
Perez, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02) :323-329
[7]  
GRAHAM MV, 1999, LEVITT TAPLEYS TECHN, P315
[8]   Optimization of helical tomotherapy treatment plans for prostate cancer [J].
Grigorov, G ;
Kron, T ;
Wong, E ;
Chen, J ;
Sollazzo, J ;
Rodrigues, G .
PHYSICS IN MEDICINE AND BIOLOGY, 2003, 48 (13) :1933-1943
[9]   Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation [J].
Grills, IS ;
Yan, D ;
Martinez, AA ;
Vicini, FA ;
Wong, JW ;
Kestin, LL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03) :875-890
[10]   Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial [J].
Hayman, JA ;
Martel, MK ;
Ten Haken, RK ;
Normolle, DP ;
Todd, RF ;
Littles, JF ;
Sullivan, MA ;
Possert, PW ;
Turrisi, AT ;
Lichter, AS .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :127-136